Tiziana life sciences announces chief medical officer invited to give presentation on intranasal foralumab on may 17

New york, may 17, 2023 (globe newswire) -- tiziana life sciences ltd. (nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that its chief medical officer is presenting at the hanson wade novel nasal formulation and delivery summit on may 17 in san diego.
TLSA Ratings Summary
TLSA Quant Ranking